<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The bcl-2 gene family plays a significant role in the propagation of cell survival and tissue modeling </plain></SENT>
<SENT sid="1" pm="."><plain>Bcl-2 was originally described in follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and is associated with the suppresion of cellular <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Evaluation for this protein has been performed for a variety of benign and malignant <z:e sem="disease" ids="C0037286" disease_type="Neoplastic Process" abbrv="">cutaneous tumors</z:e> but not to any significant extent on <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorders</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we stained biopsy specimens from diseases with interface <z:mp ids='MP_0001845'>inflammation</z:mp> (<z:e sem="disease" ids="C0023646" disease_type="Disease or Syndrome" abbrv="">lichen planus</z:e>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, and <z:hpo ids='HP_0010783'>erythema</z:hpo> multiforme) for Bcl-2 </plain></SENT>
<SENT sid="4" pm="."><plain>Epidermal expression of this protein was minimal for <z:hpo ids='HP_0000001'>all</z:hpo> three diseases; however, lymphocytes stained prominently in <z:e sem="disease" ids="C0023646" disease_type="Disease or Syndrome" abbrv="">lichen planus</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The data suggest that Bcl-2 is not prominently involved in the epidermal changes in these diseases </plain></SENT>
<SENT sid="6" pm="."><plain>The role of other members of this oncogene family in interface <z:hpo ids='HP_0000964'>dermatitis</z:hpo> still needs to be elucidated </plain></SENT>
</text></document>